Reply: BAG3 protein in advanced-stage heart failure

Alan B. Storrow*, Cathy A. Jenkins, Wesley H. Self, Pauline T. Alexander, Tyler W. Barrett, Jin H. Han, Candace D. McNaughton, Benjamin S. Heavrin, Mihai Gheorghiade, Sean P. Collins

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)675
Number of pages1
JournalJACC: Heart Failure
Volume2
Issue number6
DOIs
StatePublished - 2014

Funding

Please note: Dr. Storrow has received grant support from Abbott Diagnostics , NIH / NHLBI (K23HL085387 and K12HL1090), National Center for Advancing Translational Sciences ( UL1TR000445 ), Centers for Disease Control, and Roche Diagnostics . He consults for Roche Diagnostics, Abbott Point-of-Care, Astellas, and Novartis Pharmaceuticals Corp, USA. Dr. Barrett is supported by grant K23HL102069 and serves as a consultant for Red Bull GmbH. Dr. Collins receives research funding from NIH / NHLBI , Medtronic , Cardiorentis , Abbott Point-of-Care , Novartis , The Medicines Company , and Radiometer and consults with Trevena, Novartis, Otsuka, Radiometer, The Medicines Company, Medtronic, and Astellas. Dr. Self has received research funding from the Centers for Disease Control and Prevention , the NIH, Affinium Pharmaceuticals , bioMerieux , Astute Medical , and CareFusion Inc . Dr. Han is supported by funding from the Emergency Medicine Foundation Career Development Award and NIH K23AG032355 , and the National Center for Advancing Translational Sciences UL1 TR000445 . Dr. Gheorghiade has received consulting fees from Bayer, Novartis, Sigma Tau, Johnson & Johnson, Takeda, Otsuka, and Medtronic. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this